Epoxi Dynabeads™ M-270
Epoxi Dynabeads™ M-270
Invitrogen™

Epoxi Dynabeads™ M-270

Los gránulos de epoxi Dynabeads™ M-270 son gránulos superparamagnéticos de 2,8 μm que contienen grupos de epoxi de superficie. LosMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
14302D300 mg
1430160 mg
Número de catálogo 14302D
Precio (CLP)
2.201.561
Each
Añadir al carro de la compra
Cantidad:
300 mg
Precio (CLP)
2.201.561
Each
Añadir al carro de la compra
Los gránulos de epoxi Dynabeads™ M-270 son gránulos superparamagnéticos de 2,8 μm que contienen grupos de epoxi de superficie. Los gránulos se unen de forma covalente a los grupos de aminoácidos primarios o de sulfhidrilos en proteínas y péptidos, por lo que constituyen la opción ideal para el acoplamiento de anticuerpos, péptidos, proteínas intactas y enzimas funcionales. Estos gránulos de pH neutro hidrófilos presentan una unión inespecífica extremadamente baja de proteínas y tintes, lo que reduce la necesidad de agentes bloqueantes. Además, los gránulos de epoxi Dynabeads™ M-270 no contienen detergente Tween™ y, por lo tanto, son ideales para su uso en análisis de espectrometría de masas (MS).

• Ideales para la inmunoprecipitación (IP) de proteínas y complejos de proteínas
• La separación magnética suave y rápida y los tiempos de incubación cortos permiten la identificación de complejos lábiles y transitorios
• El acoplamiento covalente de anticuerpos a los Dynabeads™ evita la coelución del anticuerpo con la proteína objetivo

Adaptable a varias aplicaciones
Una cinética de unión a superficie rápida y sus características de separación magnética rápida convierten a los gránulos de epoxi Dynabeads™ M-270 en la opción ideal para aplicaciones como inmunoprecipitación/purificación de proteínas y complejos de proteínas, acoplamiento de enzimas funcionales a la superficie del gránulo para ensayos posteriores e identificación de miembros de unión a proteínas. Las proteínas y los complejos de proteínas capturados se separan, se lavan y se eluyen con facilidad mediante el imán DynaMag™, así como las propiedades de separación magnética de Dynabeads™.

Procedimiento de acoplamiento
El acoplamiento covalente se realiza durante la noche mediante la incubación del ligando deseado (comúnmente anticuerpos, péptidos o proteínas) con los gránulos de epoxi Dynabeads™ M-270. La capacidad de unión varía en función del ligando utilizado, pero normalmente es de 5 a 10 μg de IgG por miligramo de gránulos. El acoplamiento se produce con pH neutro y una alta concentración de sal. La reacción del acoplamiento se puede realizar a una amplia gama de temperaturas para equipararse a las características de estabilidad del ligando.

Tras la finalización del paso de acoplamiento del ligando, se desactivan las fracciones reactivas en los gránulos de epoxi Dynabeads™ M-270 para evitar acoplamiento adicional. Una vez se ha completado la reacción del acoplamiento, estos gránulos de pH neutro, no porosos e hidrófilos presentan una unión inespecífica extremadamente baja.

Más información sobre™ productos Dynabeads
• Consulte Productos Dynabeads™ para toda una gama de aplicaciones.
• Consulte imanes para separaciones de Dynabeads™
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Diámetro (métrico)2,8 μm
Volumen de elución mín5 μl
FormatoLiofilizado
Compatibilidad de alto rendimientoCompatible con alto rendimiento
Grado de pureza o calidadCalidad para investigación
Cantidad300 mg
Tipo de muestraCualquier tipo de muestra
Duración de almacenamiento24 meses a partir de la fecha de fabricación
Condiciones de envíoTemperatura ambiente
Funcionalidad de superficieEpoxi
Línea de productosDYNAL, Dynabeads
TipoGránulo de epoxi
Unit SizeEach
Contenido y almacenamiento
Contiene: 300 mg de epoxi Dynabeads™ M-270, ∼6,7 × 107 gránulos/mg, suministrados como polvo liofilizado

Almacenamiento: 2 °C a 8 °C

Preguntas frecuentes

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

How can I determine coupling efficiency of Dynabeads magnetic beads?

There are different methods to check binding of ligands to the beads, including optical density (OD) measurement, fluorescent labeling, and radioactive labeling.

For OD measurement, you would measure the OD of the ligand before immobilization to the beads and compare it with the ligand concentration that is left in the supernatant after coating. This gives a crude measurement of how much protein has bound to the beads.

Protocol:

1.Set spectrophotometer to the right wavelength. As a blank, use the Coupling Buffer.
2.Measure the absorbance of the Pre-Coupling Solution. A further dilution may be necessary to read the absorbance, depending upon the amount of ligand added.
3.Measure the absorbance of the Post-Coupling Solution. A dilution may be necessary to read the absorbance.
4.Calculate the coupling efficiency, expressed as the % protein uptake, as follows. [(Pre-Coupling Solution x D) - (Post-Coupling Solution x D)] x 100/(Pre-Coupling Solution x D) where D = dilution factor.

For fluorescent labeling, we suggest negatively quantifying the amount of ligand bound by measuring ligand remaining in the coupling supernatant (compared to the original sample), rather than directly measuring the ligands on the beads. Add labeled ligand to the beads, and measure how much ligand is left in the supernatant (not bound to the beads). By comparing this with the total amount added in the first place, you can then calculate how much of the ligand that has been bound to the beads. Keep in mind that the Dynabeads magnetic beads are also autofluorescent, which is why direct measuring of fluorescence of the bead-bound ligands is not recommended, but rather this indirect approach. The label could be, for example, FITC/PE. Some researchers perform a direct approach with success (using a flow cytometer).

Radioactive labeling is the most sensitive method of the three, but it is also the most difficult one. It involves radioactively labeling a portion of the ligand. We use radiolabeled I-125 in tracer amounts and mix it with "cold" ligands in a known ratio before coupling. The absolute quantities for the ligand on the beads should be obtained by measuring the beads in a scintillation (gamma) counter and comparing the cpm with a standard.

Protocol:

1.Take out an appropriate amount of beads and wash the beads in 1 mL of binding buffer.
2.Pipette out desired amount of human IgG in a separate tube.
3.Mix the human IgG with I-125-labeled human IgG (30,000 - 100,000 cpm).
4.Dilute the mixture of human IgG and I-125-labeled human IgG to 100 mL in binding buffer.
5.Incubate for 30 minutes at room temperature and measure the cpm in a scintillation counter.
6.Wash the beads (with coating) four times, and measure cpm again.
The % binding is calculated by using the equation : (cpm after washing/cpm before washing)x100%.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Citations & References (2)

Citations & References
Abstract
AFFIRM--a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis.
Authors:Säll A, Carlsson F, Olsson N, Wingren C, Ohlin M, Persson H, Waldemarson S
Journal:
PubMed ID:25337893
Targeted measurements of low abundance proteins in complex mixtures are in high demand in many areas, not the least in clinical applications measuring biomarkers. We here present the novel platform AFFIRM (AFFInity sRM) that utilizes the power of antibody fragments (scFv) to efficiently enrich for target proteins from a complex ... More
A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.
Authors:Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE
Journal:EBioMedicine
PubMed ID:27333027
Blood cultures, and molecular diagnostic tests that directly detect pathogen DNA in blood, fail to detect bloodstream infections in most infected patients. Thus, there is a need for a rapid test that can diagnose the presence of infection to triage patients, guide therapy, and decrease the incidence of sepsis. ... More